Los Angeles, CA -- (SBWIRE) -- 03/27/2019 -- Tinea infections are fungal infections caused by T rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte fungus thrives in humid conditions. The clinical features of tinea pedis include patchy and dry scaling on foot and presence of blisters or pustules on feet and between toes.
The rising prevalence of diabetes that is fueling the incidence of tinea pedis is one of the primary growth factors for this market. There is an increased prevalence of diabetes across the globe due to high levels of sugar in the blood streams and this results in numerous health issues. Diabetes reduces the quality of life, increases the risk of obesity, and early death. People with diabetes tend to be more resistant to antifungal treatment regimens due to high blood glucose levels which increases the chances of fungal growth. Consequently, diabetes patients tend to have a high risk of foot ulcerations and infections that can lead to tinea pedis or onychomycosis resulting in the need for the effective treatment of this infection.

North America is the largest and reflects a high market attractiveness index. APEJ is the second largest regional market for tinea pedis treatment in terms of valuation and is the fastest growing region with a high CAGR of 6.1% recorded during the period of forecast.

This report focuses on Tinea Pedis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tinea Pedis Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Get PDF of this report template: https://www.qyresearch.com/sample-form/form/986507/global-tinea-pedis-treatment-industry-depth-survey-report-

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

GSK

Exeltis USA

Valeant

Incyte

Celgene

Hisamitsu Pharmaceutical

NovaBiotics

Elorac

F. Hoffmann-La Roche

Sanofi

Teva Pharmaceutical

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Interdigital

Vesicular

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Drug Stores

Others

Get Full Report Now at USD 2,900: https://www.qyresearch.com/settlement/pre/33bccba2a5d54277126c30de4f995f46,0,1,Global%20Tinea%20Pedis%20Treatment%20Industry%20Depth%20Survey%20Report%202019

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.